🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

22 recruiting trials

for Moyamoya Disease

Imaging in Moyamoya Disease - Study to Investigate Different Imaging Technologies for a Better Understanding of Various Imaging Techniques to Evaluate Cerebral Hemodynamics, Disease-activity and Possibly the Etiology in Moyamoya Patients NCT06330818NA1 site📍 Tübingen University Hospital Tuebingen · Tests: MRI, H2 15O PET/CT, Biosampling Neurosurgical Outcome Network NCT06724029n/a27 sites📍 Bergamo📍 Brescia📍 Brescia Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta Study on the Mechanism of Cognitive Impairment in Patients with Moyamoya Disease NCT06832839n/a1 site📍 Beijing Beijing Tiantan Hospital · Tests: Revascularization Cognitive-Motor Incorporated Training and Its Relations in Cerebrovascular Diseases With Cognitive and Motor Impairments NCT07144930NA1 site📍 Taipei National Taiwan University Hospital · Tests: MCIT program, Motor training program Family-Based Moyamoya Susceptibility and Early Detection NCT07517354n/a1 site📍 Beijing Beijing Tiantan Hospital · Tests: 5T High-Resolution MRI Treatment of Moyamoya Disease With iPSC-derived Exosomes NCT07065409Phase 11 site📍 Wuhan Huaqiu Zhang · Tests: iPSC-EVs Development and Validation of Risk Prediction Models for Stroke and Cognitive Impairment in Moyamoya Disease and Moyamoya Syndrome NCT07894107n/a13 sites📍 Beijing📍 Beijing📍 Beijing Beijing Tiantan Hospital Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites📍 Sioux Falls📍 Sydney Sanford Health The Evolution and Prognosis of Moyamoya Disease NCT05619068n/a1 site📍 Beijing Chinese PLA General Hospital Managing Transient Neurologic Episodes in Surgery for Moyamoya Disease NCT06880341n/a1 site📍 Palo Alto Stanford University · Tests: Standard of Care The Symani Restore Study NCT07140731NA1 site📍 Buffalo Jacobs institute · Tests: Symani Surgical System A Multicenter, Prospective, Double-blind, Randomized Controlled Study on the Efficacy and Safety of Ischemic Preconditioning Therapy Versus Optimal Medical Therapy in Reducing the Recurrence of Ischemic Events in Symptomatic Moyamoya Disease NCT07889531NA1 site📍 Beijing Beijing Tiantan Hospital · Tests: remote ischemic conditioning (RIC), Control Cardiac Index-Guided Intraoperative Hemodynamic Management in Pediatric Moyamoya Surgery NCT07304947NA1 site📍 Seoul Seoul National University Hospital · Tests: Cardiac Index-Guided Hemodynamic Management, Blood Pressure-Guided Standard Hemodynamic Management Remimazolam Consumption: TCI vs. Manual Infusion NCT07377695NA1 site📍 Seongnam-si Seoul National University Hospital · Tests: Target-Controlled Infusion (TCI) of Remimazolam, Manual Infusion of Remimazolam Nicotinamide Riboside (NR) to Treat Moyamoya-like Cerebrovascular Disease in Smooth Muscle Dysfunction Syndrome (SMDS) NCT06280482Phase 11 site📍 Houston The University of Texas Health Science Center, Houston · Tests: Nicotinamide riboside (NR) Functional Magnetic Resonance-Based Observations of Brain Networks in Moyamoya Disease Patients Under Anesthesia NCT06041659n/a1 site📍 Beijing Beijing Tiantan Hospital 5T MRI and Metabolomics-Based Hemorrhage Risk Prediction in Moyamoya Disease NCT07781579n/a1 site📍 Beijing Beijing Hospital Application of Extended Reality (XR)-Assisted Computed Tomography (CT)-Guided Localization in Extracranial-intracranial (EC-IC) Bypass Surgery NCT07711457n/a1 site📍 Taipei National Taiwan University Hospital · Tests: NTU OpVerse surgical simulation platform Long-term Outcomes of Conservative Management in Patients with Moyamoya Disease and Their First-degree Relatives (LAMORA) NCT05332756n/a1 site📍 Beijing Beijing Tiantan Hospital · Tests: Conservative management Application of Digital Twins' Technology in Patients Who Had a Stroke, With Moyamoya Disease and With Cerebral Amyloid Angiopathy (CAA) During the Secondary Prevention Phase: A Proof of Concept Using a Randomized Control Trial (Clinical Study 6, STRATIF-AI Project) NCT06714097NA1 site📍 Milan Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Tests: AI, healthy dialogue Study on Evaluating the Effectiveness of Statins in the Treatment of Moyamoya Disease NCT06817434n/a1 site📍 Beijing Beijing Tiantan Hospital · Tests: Revascularization/Conservative management Registry of Multicenter Brain-Heart Comorbidity in China NCT05961748n/a14 sites📍 Beijing📍 Beijing📍 Beijing Beijing Tiantan Hospital · Tests: Multi-disciplinary assessment
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy